Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,972 | -5,333 | -2,923 | -10,503 | -17,100 |
| Depreciation Amortization | 612 | 243 | 790 | 1,152 | N/A |
| Accounts receivable | -132 | -243 | -141 | 115 | N/A |
| Other Working Capital | -28,555 | 11,898 | -1,046 | -840 | N/A |
| Other Operating Activity | 121 | 19,172 | -4,322 | 1,504 | -5,570 |
| Operating Cash Flow | $-10,982 | $25,736 | $-7,641 | $-8,573 | $-22,670 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,138 | -9,046 | -2,000 | N/A | N/A |
| PPE Investments | -372 | -45 | -36 | -8 | N/A |
| Other Investing Activity | 0 | 0 | -101 | 0 | 5,690 |
| Investing Cash Flow | $-7,510 | $-9,090 | $-2,137 | $-8 | $5,690 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 231 | N/A | N/A |
| Debt Issued | N/A | N/A | 1,796 | 4,534 | N/A |
| Debt Repayment | -364 | -6,000 | N/A | N/A | N/A |
| Common Stock Issued | 460 | 746 | 168 | N/A | N/A |
| Other Financing Activity | 0 | 5,000 | -5,000 | 1,121 | 20,390 |
| Financing Cash Flow | $96 | $-254 | $-2,806 | $5,656 | $20,390 |
| Beginning Cash Position | 20,923 | 1,532 | 2,552 | 5,608 | 2,200 |
| End Cash Position | 2,528 | 20,923 | 1,532 | 2,552 | 5,600 |
| Net Cash Flow | $-18,396 | $19,391 | $-1,020 | $-3,056 | $3,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,982 | 25,736 | -7,641 | -8,573 | -22,670 |
| Capital Expenditure | -372 | -90 | -36 | -8 | N/A |
| Free Cash Flow | -11,354 | 25,646 | -7,676 | -8,581 | -22,670 |